Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (131-140 of 333) with videos related to

Pageof 34
Sort By:
Oncology Reports|December 17, 2008
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancerYuji Bessho, Tetsuya Oguri, Hiroaki Ozasa, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2005
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR)Hiromichi Ebi, Yasushi Sigeoka, Toshiaki Saeki, et al.
Cancer Science|August 25, 2019
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myelomaKeiko Maekawa, Masaki Ri, Miki Nakajima, et al.
Journal of Virology|October 29, 2005
Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype EKei Fujiwara, Yasuhito Tanaka, Emma Paulon, et al.
Cancer Science|January 6, 2011
Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myelomaSandra Grass, Shinsuke Iida, Aleksandra Wikowicz, et al.
Journal of Gastroenterology and Hepatology|September 17, 2003
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infectionSeiji Suzuki, Yasuhito Tanaka, Etsuro Orito, et al.
Journal of Medical Virology|June 10, 2003
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver diseaseFuminaka Sugauchi, Tomoyoshi Ohno, Etsuro Orito, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 15, 2006
Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infectionNoboru Shinkai, Yasuhiro Tanaka, Etsuro Orito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecifiedTakashi Ishida, Hiroshi Inagaki, Atae Utsunomiya, et al.
Journal of Medical Virology|August 26, 2003
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infectionYuko Hattori, Etsuro Orito, Tomoyoshi Ohno, et al.
Pageof 34

Showing results (131-140 of 333) with videos related to

Sort By:
Pageof 34
Oncology Reports|December 17, 2008
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancerYuji Bessho, Tetsuya Oguri, Hiroaki Ozasa, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2005
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR)Hiromichi Ebi, Yasushi Sigeoka, Toshiaki Saeki, et al.
Cancer Science|August 25, 2019
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myelomaKeiko Maekawa, Masaki Ri, Miki Nakajima, et al.
Journal of Virology|October 29, 2005
Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype EKei Fujiwara, Yasuhito Tanaka, Emma Paulon, et al.
Cancer Science|January 6, 2011
Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myelomaSandra Grass, Shinsuke Iida, Aleksandra Wikowicz, et al.
Journal of Gastroenterology and Hepatology|September 17, 2003
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infectionSeiji Suzuki, Yasuhito Tanaka, Etsuro Orito, et al.
Journal of Medical Virology|June 10, 2003
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver diseaseFuminaka Sugauchi, Tomoyoshi Ohno, Etsuro Orito, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 15, 2006
Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infectionNoboru Shinkai, Yasuhiro Tanaka, Etsuro Orito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecifiedTakashi Ishida, Hiroshi Inagaki, Atae Utsunomiya, et al.
Journal of Medical Virology|August 26, 2003
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infectionYuko Hattori, Etsuro Orito, Tomoyoshi Ohno, et al.
Pageof 34